CD8A and metastatic melanoma: demonstrated that CD8+ T cells located at the invasive tumor margin are associated with the PD‐1/PD‐L1 immune inhibitory axis and may predict response to PD‐1 blockade in metastatic melanoma.[67] Conversely, Gide et al.